(Q44365146)

2 December 2017

title

Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas (English)

1 reference

2 December 2017

1 reference

11

Harry V Vinters

1 reference

2 December 2017

Ingrid Fackler

1

1 reference

2 December 2017

Jeffrey E DeClue

2

1 reference

2 December 2017

Heidi Rust

3

1 reference

2 December 2017

Phuong-Anh Vu

4

1 reference

2 December 2017

Heinz Kutzner

5

1 reference

2 December 2017

Arno Rütten

6

1 reference

2 December 2017

Steven Kaddu

7

1 reference

2 December 2017

Christian A Sander

8

1 reference

2 December 2017

Matthias Volkenandt

9

1 reference

2 December 2017

Michael W Johnson

10

1 reference

2 December 2017

Ralf Wienecke

12

1 reference

2 December 2017

publication date

1 March 2003

1 reference

Journal of Cutaneous Pathology

2 December 2017

published in

1 reference

2 December 2017

volume

30

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

174-177

1 reference

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Identification and characterization of the tuberous sclerosis gene on chromosome 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

The cutaneous features of tuberous sclerosis: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Adenoma sebaceum of Pringle: A clinicopathologic review, with a discussion of related pathologic entities

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Prevalence of tuberous sclerosis estimated by capture-recapture analysis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Variability of expression in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Loss of heterozygosity in tuberous sclerosis hamartomas.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0560.2003.2O066.X

7 January 2021

10.1034/J.1600-0560.2003.2O066.X

Identifiers

DOI

1 reference

2 December 2017

1 reference